Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPVID Study of nomacopan for SARS-CoV-2 pneumonia
RBR-88bjcvPhase 2Recruiting
- Sponsor
- Hospital Eduardo de Menezes
- Start
- Aug 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nomacopan in coronavirus pneumonia (3 arms), sponsored by Hospital Eduardo de Menezes. Started Aug 2020; status: recruiting.
02
Drugs
nomacopan
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on RBR-88bjcv.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-88bjcv.